聚素-1作为外周动脉疾病的新生物标志物:试点前性研究的发现
P G Theodoridis1, S Georgopoulos2, C Bakoyiannis2
13rd Department of Vascular Surgery, Athens Medical Center, Athens, Greece.
Annals of vascular surgery
|July 24, 2025
概括
聚西斯-1 (PC-1) 可能是动脉动脉样硬化的一个生物标志物,与疾病严重程度和机械传导途径相关. 需要进一步的研究来确认其作为治疗点的作用.
科学领域:
- 血管生物学 血管生物学
- 生物标志物发现发现
- 机械生物学 机械生物学
背景情况:
- 动脉样硬化是全球主要的健康问题.
- 像Polycystin-1 (PC-1) 这样的机械敏感分子与血管病理有关.
- PC-1在动脉样硬化中的作用尚不清楚.
研究的目的:
- 在接受动脉内关节切除术的患者中评估血清PC-1水平.
- 调查PC-1与动脉样硬化斑块特征的关联.
- 探索PC-1和p53/p38/p21信号通路之间的关系.
主要方法:
- 预计将招募70名接受动脉内关节切除术的患者.
- 通过ELISA测量血清PC-1水平.
- 对p53/p38/p21通路激活的西部斑点分析.
- PC-1,临床参数,斑块特征和蛋白质表达之间的相关性分析.
主要成果:
- 在10名患者中检测到PC-1,与年龄,BMI,脂质样本,HbA1c和心血管狭窄症严重程度有显著的相关性.
- 在PC-1-阳性样本中观察到增加的p21和-p38表达.
- 热图分析表明PC-1-阳性样本中的p53/p38/p21激活率更高,特别是在男性中.
结论:
- PC-1 可能作为一个潜在的生物标志物用于动脉样硬化.
- 研究结果表明,这对疾病进展和机械传导有影响.
- 需要进行更大规模的研究来验证PC-1的作用和治疗潜力.
更多相关视频
相关概念视频
Peripheral Artery Disease I: Introduction
33
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
33
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
35
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
35
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
216
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
216
Peripheral Artery Disease III: Interprofessional Care
29
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
29
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
40
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
40
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
337
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
337


